Practice Areas
HomePractice AreasExpertsNewsContact UsEmployment
 
 

Practice Areas

Antitrust and Competition Analysis

Navigant Economics provides economic analysis in litigation and regulatory proceedings involving competition issues. Our experts have provided testimony in proceedings before District Courts, the Department of Justice, the Federal Trade Commission, the Federal Communications Commission, the Federal Energy Regulatory Commission, and numerous state Public Utilities Commissions.

We provide economic analysis and testimony in connection with mergers and acquisitions and antitrust claims of:

  • Anticompetitive horizontal agreements (price fixing, bid rigging, potential anticompetitive effects of joint ventures)
  • Unilateral conduct (predatory pricing, refusals to deal, monopolization via patent fraud)
  • Vertical restraints (exclusive dealing, requirement contracting, tying and bundling)

We also offer economic analysis and testimony on issues of price and rate of return regulation, mandatory access, quality of service, and benefit-cost analysis, with especial expertise in regulatory proceedings involving communications and the Internet (software and hardware sectors, network unbundling and “net neutrality” issues affecting telecom and cable firms, retransmission consent and other content-related issues, and the range of wireless spectrum issues) and all types of energy markets.

Some of our Principals teach courses in antitrust, law and economics, price theory (including the economics of monopoly and oligopoly), regulated industries, and related topics at The University of Chicago, Kellogg Graduate School of Management at Northwestern University, George Mason Law School, Loyola University Chicago School of Law, University of Virginia and other top academic institutions.

   

Antitrust and Competition Analysis
Auctions and Market Design
Class Certification
Communications and the Internet
Consumer Protection
Damages
Discrimination/Labor
Finance, Securities Litigation and Valuation
Healthcare and Pharmaceuticals
Intellectual Property